Abiomed Announces Preliminary Fourth Quarter Revenue of $43.7 Million, Driven by Record Number of Patients Supported

[at noodls] – DANVERS, Mass., April 17, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported preliminary fourth quarter fiscal 2013 revenue … more

View todays social media effects on ABMD

View the latest stocks trending across Twitter. Click to view dashboard

See who ABIOMED is hiring next, click here to view